Prognosis of a second clinical event from baseline MRI in patients with a CIS: a multicenter study using a machine learning approach.

Clinically isolated syndrome Machine learning Magnetic resonance imaging Multiple sclerosis Prognosis Support vector machine

Journal

Neuroradiology
ISSN: 1432-1920
Titre abrégé: Neuroradiology
Pays: Germany
ID NLM: 1302751

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 27 08 2021
accepted: 15 12 2021
pubmed: 21 1 2022
medline: 11 6 2022
entrez: 20 1 2022
Statut: ppublish

Résumé

To predict the occurrence of a second clinical event in patients with a CIS suggestive of MS, from baseline magnetic resonance imaging (MRI), by means of a pattern recognition approach. Two hundred sixty-six patients with a CIS were recruited from four participating centers. Over a follow-up of 3 years, 130 patients had a second clinical episode and 136 did not. Grey matter and white matter T1-hypointensities masks segmented from 3D T1-weighted images acquired on 3 T scanners were used as features for the classification approach. Differences between CIS that remained CIS and those that developed a second event were assessed at a global level and at a regional level, arranging the regions according to their contribution to the classification model. All classification metrics were around or even below 50% for both global and regional approaches. Accuracies did not change when T1-hypointensity maps were added to the model; just the specificity was increased up to 80%. Among the 30 regions with the largest contribution, 26 were grey matter and 4 were white matter regions. For grey matter, regions contributing showed either a larger or a smaller volume in the group of patients that remained CIS, compared to those with a second event. The volume of T1-hypointensities was always larger for the group that presented a second event. Prediction of a second clinical event in CIS patients from baseline MRI seems to present a highly heterogeneous pattern, leading to very low classification accuracies. Adding the T1-hypointensity maps does not seem to improve the accuracy of the classification model.

Identifiants

pubmed: 35048162
doi: 10.1007/s00234-021-02885-7
pii: 10.1007/s00234-021-02885-7
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1383-1390

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI18/00823

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Miller DH, Chard DT, Ciccarelli O (2012) Clinically isolated syndromes. Lancet Neurol 11(2):157–169
doi: 10.1016/S1474-4422(11)70274-5
Lassmann H (2008) The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am 18(4):563–576
doi: 10.1016/j.nic.2008.06.005
Filippi M, Preziosa P, Banwell BL et al (2019) Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain 142(7):1858–1875
doi: 10.1093/brain/awz144
Sastre-Garriga J, Pareto D, Battaglini M et al (2020) MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nat Rev Neurol 16(3):171–182
doi: 10.1038/s41582-020-0314-x
Kuhle J, Disanto G, Dobson R et al (2015) Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study. Mult Scler 21(8):1013–1024
doi: 10.1177/1352458514568827
Tintoré M, Rovira A, Río J et al (2006) Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology 67(6):968–972
doi: 10.1212/01.wnl.0000237354.10144.ec
Zhang H, Alberts E, Pongratz V et al (2018) Predicting conversion from clinically isolated syndrome to multiple sclerosis-an imaging-based machine learning approach. Neuroimage Clin S2213–1582(18):30341–30343
Wottschel V, Alexander DC, Kwok PP et al (2014) Predicting outcome in clinically isolated syndrome using machine learning. Neuroimage Clin 7:281–287
doi: 10.1016/j.nicl.2014.11.021
Wottschel V, Chard DT, Enzinger C et al (2019) SVM recursive feature elimination analyses of structural brain MRI predicts near-term relapses in patients with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage Clin. 24:102011
doi: 10.1016/j.nicl.2019.102011
Bendfeldt K, Taschler B, Gaetano L et al (2019) MRI-based prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis using SVM and lesion geometry. Brain Imaging Behav 13(5):1361–2137
doi: 10.1007/s11682-018-9942-9
Schrouff J, Rosa MJ, Rondina JM et al (2013) PRoNTo: pattern recognition for neuroimaging toolbox. Neuroinformatics 11(3):319–337
doi: 10.1007/s12021-013-9178-1
Schrouff J, Monteiro JM, Portugal L et al (2018) Embedding anatomical or functional knowledge in whole-brain multiple kernel learning models. Neuroinformatics 16(1):117–143
doi: 10.1007/s12021-017-9347-8
Tzourio-Mazoyer N, Landeau B, Papathanassiou D et al (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15(1):273–289
doi: 10.1006/nimg.2001.0978
Mori S, Oishi K, Jiang H et al (2008) Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage 40(2):570–582
doi: 10.1016/j.neuroimage.2007.12.035
Henry RG, Shieh M, Okuda DT et al (2008) Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 79(11):1236–1244
doi: 10.1136/jnnp.2007.134825
Pérez-Miralles F, Sastre-Garriga J, Tintoré M et al (2013) Clinical impact of early brain atrophy in clinically isolated syndromes. Mult Scler 19(14):1878–1886
doi: 10.1177/1352458513488231
Audoin B, Zaaraoui W, Reuter F et al (2010) Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis. J Neurol Neurosurg Psychiatry 81(6):690–695
doi: 10.1136/jnnp.2009.188748
Pareto D, Sastre-Garriga J, Alberich M et al (2019) Brain regional volume estimations with NeuroQuant and FIRST: a study in patients with a clinically isolated syndrome. Neuroradiology 61(6):667–767
doi: 10.1007/s00234-019-02191-3

Auteurs

Deborah Pareto (D)

Department of Radiology (IDI), Neuroradiology Section, Hospital Universitari Vall d'Hebron and Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain. deborah.pareto.idi@gencat.cat.

Aran Garcia-Vidal (A)

Department of Radiology (IDI), Neuroradiology Section, Hospital Universitari Vall d'Hebron and Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Sergiu Groppa (S)

Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Gabriel Gonzalez-Escamilla (G)

Department of Neurology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Mara Rocca (M)

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Massimo Filippi (M)

Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Vita-Salute San Raffaele University, Milan, Italy.

Christian Enzinger (C)

Department of Neurology, Medical University of Graz, Graz, Austria.

Michael Khalil (M)

Department of Neurology, Medical University of Graz, Graz, Austria.

Sara Llufriu (S)

Center of Neuroimmunology, Advanced Imaging in Neuroimmunological Diseases (ImaginEM) Group, Hospital Clinic, IDIBAPS and Universitat de Barcelona, Barcelona, Spain.

Mar Tintoré (M)

Department of Neurology/Neuroimmunology, Multiple Sclerosis Center of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Jaume Sastre-Garriga (J)

Department of Neurology/Neuroimmunology, Multiple Sclerosis Center of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.

Àlex Rovira (À)

Department of Radiology (IDI), Neuroradiology Section, Hospital Universitari Vall d'Hebron and Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH